Adaptimmune Therapeutics PLC - SPONDS ADR (ADAP)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / SPONDS ADR
Number of holders
84
Total Shares
145M
Shares change
+28.7M
Total reported value, excl. options
$134M
Value change
+$26.6M
Put/Call ratio
0.4
Number of buys
55
Number of sells
-20
Price
$0.93
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.